Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Methods and systems for time-shifting content
Method for switching channels in a wireless communication network
Lower set insert with a lower ball seat for a downhole plug
Context data in UPNP service information
Methods and systems for detecting icing conditions
Cosmetic composition based on a supramolecular polymer and a hyperbranched functional polymer
Generating compiled code that indicates register liveness
  Randomly Featured Patents
Rotary ditch cleaning device
Non-ALG approach for application layer session traversal of IPv6/IPv4 NAT-PT gateway
Alternate port apparatus for manufacturing test of integrated serial bus and method therefor
Focusing method and apparatus, and recording medium for recording the method
Apparatus for closing a metallic shield around a cable core
Polyaromatic amine curing agents for epoxy resins
Display sign for automobile windows
Compressor bearings
Mechanism for changing inductance of a push-button tuner
Vacuum cleaning tool for a vacuum cleaning apparatus